These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7470462)

  • 1. Dissociation of antithrombin III--thrombin complex. Formation of active and inactive antithrombin III.
    Griffith MJ; Lundblad RL
    Biochemistry; 1981 Jan; 20(1):105-10. PubMed ID: 7470462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of complexes and their derivatives formed during inhibition of bovine thrombin and activated factor X by antithrombin III.
    Jesty J
    J Biol Chem; 1979 Feb; 254(4):1044-9. PubMed ID: 762113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
    Danielsson A; Björk I
    Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.
    Griffith MJ
    J Biol Chem; 1982 Dec; 257(23):13899-302. PubMed ID: 7142182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of antithrombin III and thrombin-antithrombin III complex with cultured aortic endothelial cells.
    Bartha K; Kovács T; Léránt I; Papp B; Csonka E; Kolev K; Machovich R
    Thromb Res; 1987 Sep; 47(5):541-52. PubMed ID: 3672436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin.
    Speight MO; Griffith MJ
    Arch Biochem Biophys; 1983 Sep; 225(2):958-63. PubMed ID: 6625618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
    Griffith MJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5460-4. PubMed ID: 6577437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin III.
    Walker FJ; Esmon CT
    J Biol Chem; 1979 Jul; 254(13):5618-22. PubMed ID: 447671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of thrombin by antithrombin is accompanied by inactivation of regulatory exosite I.
    Bock PE; Olson ST; Björk I
    J Biol Chem; 1997 Aug; 272(32):19837-45. PubMed ID: 9242645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of monoclonal antibodies against the human thrombin-antithrombin III complex.
    Asakura S; Yoshida N; Matsuda M; Murayama H; Soe G
    Biochim Biophys Acta; 1988 Jan; 952(1):37-47. PubMed ID: 3422029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of thrombin, plasmin, thrombin-antithrombin III complex and plasmin-antithrombin III complex with isolated hepatocytes.
    Spolarics Z; Kalapos MP; Léránt I; Garzó T; Antoni F; Mandl J; Machovich R
    Biochim Biophys Acta; 1989 Aug; 1012(3):231-6. PubMed ID: 2547438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-like tubings. III. Kinetics and mechanism of thrombin, antithrombin III and thrombin-antithrombin complex adsorption under controlled-flow conditions.
    Migonney V; Fougnot C; Jozefowicz M
    Biomaterials; 1988 Sep; 9(5):413-8. PubMed ID: 3224126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation and stability of the complex formed between human antithrombin-III and thrombin.
    Ferguson WS; Finlay TH
    Arch Biochem Biophys; 1983 Jan; 220(1):301-8. PubMed ID: 6338832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody that triggers deacylation of an intermediate thrombin-antithrombin III complex.
    Asakura S; Matsuda M; Yoshida N; Terukina S; Kihara H
    J Biol Chem; 1989 Aug; 264(23):13736-9. PubMed ID: 2474535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.
    Lollar P; Owen WG
    J Clin Invest; 1980 Dec; 66(6):1222-30. PubMed ID: 6255009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular weight analysis of antithrombin III-heparin and antithrombin III-thrombin-heparin complexes.
    Pletcher CH; Cunningham MT; Nelsestuen GL
    J Biol Chem; 1986 Mar; 261(9):4143-7. PubMed ID: 3949807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin.
    Nesheim ME
    J Biol Chem; 1983 Dec; 258(23):14708-17. PubMed ID: 6643505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum.
    Preissner KT; Zwicker L; Müller-Berghaus G
    Biochem J; 1987 Apr; 243(1):105-11. PubMed ID: 3606566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dependence of the rate of thrombin/antithrombin III reaction upon the turnover rate of a catalytic amount of heparin.
    Oshima G
    Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2155-9. PubMed ID: 2598315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.